EUVIMEDEUVIMED entdecken
Open Access

Detection of Histoplasma capsulatum and Blastomyces dermatitidis antigens in serum using a single quantitative enzyme immunoassay

Dane Granger, Nicholas T Streck, Elitza S Theel iD

Journal of Clinical Microbiology · 17.01.2024 · 62 (1)

DOI: 10.1128/jcm.01213-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Microbiology, erschienen am 17.01.2024. Verfasst von Dane Granger und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Histoplasma, Blastomyces. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Histoplasma and Blastomyces antigen detection assays are commonly used diagnostic tools. However, a high level of cross-reactivity between these antigens prevents definitive pathogen identification by these assays alone. Retrospective analysis of 3,529 patients with Histoplasma and Blastomyces antigen testing performed on the same serum sample yielded an overall percent agreement of 99.3% (3,506 of 3,529; kappa: 0.859) between the two assays, suggesting that use of a single assay to detect both antigens may be an alternative diagnostic approach. We assessed performance of the Gotham BioTech Blastomyces antigen (GBA) enzyme immunoassay (EIA) (Portland, Maine) for detection of Blastomyces and Histoplasma antigens in serum. Comparison to the MiraVista Diagnostics Blastomyces (MVB) EIA showed 100% positive (24 of 24), negative (57 of 57), and overall (81 of 81) percent agreement. Additionally, 171 sera were used to compare the GBA EIA to the MiraVista Diagnostics Histoplasma (MVH) EIA, which showed 91.3% (63 of 69), 98% (100 of 102), and 95.3% (163 of 171) positive, negative, and overall percent agreement, respectively. Among eight patients with discordant GBA/MVH EIA results, seven had additional fungal testing performed, and results suggested that the MVH and GBA results were inaccurate for two and five samples, respectively. Overall, this study suggests that the GBA EIA has a high level of agreement with both of the commonly used, individual Blastomyces and Histoplasma antigen EIAs. By taking advantage of the high level of cross-reactivity between Blastomyces and Histoplasma antigen EIAs, utilization of a single antigen detection assay for these fungi provides an opportunity to optimize test utilization and decrease patient cost while maintaining a high level of diagnostic accuracy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistoplasmaBlastomycesHumansRetrospective StudiesAntigens, FungalImmunoenzyme Techniques

Stichwörter der Autor:innen

BlastomycesHistoplasmaantigenimmunoassayserum

Substanzen

Antigens, Fungal

Autor:innen und Institutionen

  • Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.

ORCID-Profile: Elitza S Theel

Zitieren

APA

Granger, D., Streck, N. T., & Theel, E. S. (2024). Detection of Histoplasma capsulatum and Blastomyces dermatitidis antigens in serum using a single quantitative enzyme immunoassay. Journal of Clinical Microbiology, 62(1). https://doi.org/10.1128/jcm.01213-23

Vancouver

Granger D, Streck NT, Theel ES. Detection of Histoplasma capsulatum and Blastomyces dermatitidis antigens in serum using a single quantitative enzyme immunoassay. Journal of Clinical Microbiology. 2024;62(1). doi:10.1128/jcm.01213-23

BibTeX
@article{Granger2024,
  author = {Granger, Dane and Streck, Nicholas T and Theel, Elitza S},
  title = {Detection of Histoplasma capsulatum and Blastomyces dermatitidis antigens in serum using a single quantitative enzyme immunoassay},
  journal = {Journal of Clinical Microbiology},
  year = {2024},
  volume = {62},
  number = {1},
  doi = {10.1128/jcm.01213-23}
}
Kostenlos starten →